Report · 2025 · Open access
Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling
ORBi (University of Liège) · Published 16 November 2025 · DOI 10.5281/zenodo.17624940
In brief
“Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling” is a 2025 report by Luiz Ladeira and 4 co-authors, published in ORBi (University of Liège). OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at ORBi (University of Liège).
- Citations
- 0
- Authors
- 5
Abstract
Chemical-induced heart toxicity remains a major challenge in drug development and environmental safety, largely because current testing often relies on narrow, late-stage endpoints that miss the complex biological progression of the toxicities. To address this, we developed a comprehensive Adverse Outcome Pathway (AOP) network that maps how early (bio)chemical triggers evolve into organ-level dysfunction. By integrating data from the OECD AOP-Wiki, we constructed a unified network of 64 biological events and 94 documented relationships that identifies the critical biological "crossroads" where different toxic chemicals converge to cause heart damage. Our analysis reveals a compact core of central biological events, such as oxidative stress and mitochondrial dysfunction, which act as the primary drivers of cardiac injury. This network approach moves beyond single, linear pathways to show how systemic factors, including interactions with other organs like the kidneys, contribute to cardiotoxicity. To translate these findings into a practical resource for the broader scientific community, we developed a methods catalogue that links these biological events to specific laboratory assays. To ensure this work is accessible and actionable, we hosted the network on an interactive, FAIR-aligned web platform. By providing a clear scaffold for understanding heart safety, this resource enables the design of more human-relevant, animal-free testing strategies and helps prioritise the most impactful biomarkers for future safety assessments.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ladeira, L., Barnes, D. A., Masereeuw, R., Liesbet, G., & Bernard, S. (2025). Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling. ORBi (University of Liège). https://doi.org/10.5281/zenodo.17624940
MLA 9
Ladeira, Luiz, et al. “Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling.” ORBi (University of Liège), 2025. https://doi.org/10.5281/zenodo.17624940.
Chicago
Ladeira, Luiz, Devon A. Barnes, Rosalinde Masereeuw, Geris, Liesbet, and Staumont, Bernard. 2025. “Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling.” ORBi (University of Liège). https://doi.org/10.5281/zenodo.17624940.
Harvard
Ladeira, L. et al. (2025) ‘Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling’, ORBi (University of Liège). doi:10.5281/zenodo.17624940.
IEEE
L. Ladeira, D. A. Barnes, R. Masereeuw, G. Liesbet, and S. Bernard, “Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling,” ORBi (University of Liège), 2025, doi: 10.5281/zenodo.17624940.
BibTeX
@article{ladeira2025cardiotoxicity,
title = {{Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling}},
author = {Ladeira, Luiz and Barnes, Devon A. and Masereeuw, Rosalinde and Liesbet, Geris, and Bernard, Staumont,},
journal = {ORBi (University of Liège)},
year = {2025},
doi = {10.5281/zenodo.17624940},
url = {https://doi.org/10.5281/zenodo.17624940}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- cardiotoxicity
- oxidative stress
- mitochondrial dysfunction
- mechanistic toxicology
- animal-free testing
- biomarkers
- cardiac safety assessment
Work with this paper
Most-cited papers in Veterinary
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysTim R. Mosmann · Journal of Immunological Methods · 1983 · 57,115 citations
- Guide for the Care and Use of Laboratory Animals: Eighth EditionNational Research Council · National Academies Press eBooks · 2011 · 16,572 citations
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningPhilip Skehan, Ritsa Storeng, Dominic A. Scudiero and 7 more · JNCI Journal of the National Cancer Institute · 1990 · 9,860 citations
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchCarol Kilkenny, William J. Browne, Innes C. Cuthill and 2 more · PLoS Biology · 2010 · 7,617 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia and 25 more · PLoS Biology · 2020 · 6,761 citations
Questions about this paper
How do I cite this paper in APA style?
Ladeira, L., Barnes, D. A., Masereeuw, R., Liesbet, G., & Bernard, S. (2025). Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling. ORBi (University of Liège). https://doi.org/10.5281/zenodo.17624940
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at ORBi (University of Liège): sign in and open the full text from this page.
Who wrote this paper?
Luiz Ladeira, Devon A. Barnes, Rosalinde Masereeuw, Geris, Liesbet, Staumont, Bernard.
What is the DOI of this paper?
10.5281/zenodo.17624940, permanently at https://doi.org/10.5281/zenodo.17624940. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.